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Abstract: Objective: To describe the subgingival microbiome of individuals with Down syndrome
(DS). Methods: We conducted a cross-sectional observational study that obtained bacterial DNA
samples from 50 patients with DS, 25 with periodontitis (PDS) and 25 with a healthy periodontal
condition (HDS). The samples were analyzed by sequencing the 16S rRNA gene V3–V4 hypervariable
region using the MiSeq System. Taxonomic affiliations were assigned using the naïve Bayesian
classifier integrated in QIIME2 plugins. We evaluated the difference in bacteria abundance between
the sample groups using Wilcoxon and Kruskal–Wallis tests. We evaluated the alpha diversity of
the identified species using the Observed, Chao1metric, ACE and Shannon indices and evaluated
beta diversity with principal coordinate analysis (registration code: 2018/510). Results: Twenty-one
genera and 39 bacterial species showed a significantly different abundance between the study groups.
Among the genera, Porphyromonas, Treponema, Tannerella and Aggregatibacter were more abundant in
the PDS group than in the HDS group, as were the less commonly studied Filifactor, Fretibacterium
and Desulfobulbus genera. Among the species, Porphyromonas spp. and Tannerella spp. were the most
abundant in the PDS group; the most abundant species in the HDS group were Pseudomonas spp.,
Granulicatella spp. and Gemella spp. Conclusion: Well-recognized periodontal pathogens and newly
proposed pathogenic taxa were associated with periodontitis in patients with DS.
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1. Introduction
Down syndrome (DS) is a genetic disease caused by autosomal genetic disorders, mainly the
presence of an extra chromosome in pair 21 [1]. Patients with DS have a characteristic phenotype
associated with intellectual disability [2] and often have immunological disorders and systemic
conditions, such as congenital heart disease, thyroid dysfunction and oral diseases [3].
Based on the current classification of periodontal diseases [4], periodontitis in individuals with
DS would be classified as periodontitis as a manifestation of systemic disease, given that the systemic
condition affects the course of periodontitis, resulting in an early onset of severe periodontitis [5].
In these patients, it has been suggested that a particular subgingival microbiota [6,7], together with a
defective host-response inherent to DS [8], could induce dysbiosis, thus favoring the early onset of
periodontitis [9].
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There is scarce scientific evidence of a specific subgingival microbiota in patients with DS
and periodontitis, and the few available studies have reported conflicting results. A number
of microbiological studies on patients with DS have reported a specific microbiological pattern,
with Tannerella forsythia the predominant bacterial species, followed by Treponema denticola and
Porphyromonas gingivalis, and with a prevalence significantly higher in patients with periodontitis,
compared with patients with healthy periodontium [7]. In other studies, however, the microbiota
showed no specific pattern [6]. These differences could be due to the differing technologies employed
to identify the bacteria: DNA probes and checkerboard DNA–DNA hybridization [6] and polymerase
chain reaction (PCR) [7]. Although these methods are very specific, they are not sensitive enough to
detect low numbers of bacteria and cannot identify nonspecific bacteria.
With the use of the reference gene, massive sequencing techniques and bioinformatics tools for
treating the data, we have been able to obtain unprecedented information on the human microbiome,
in terms of the taxonomy and function of microorganisms [10]. The aim of this study is to use
next-generation sequencing (NGS) to study the subgingival microbiota of patients with DS to determine
whether those patients with periodontitis have a differential pattern when compared with patients
with DS but no periodontitis.
2. Materials and Methods
2.1. Study Design and Population
We designed a cross-sectional observational study for a White Spanish population with DS.
The study was conducted in accordance with the Declaration of Helsinki of the World Medical
Association (2008) and approved by the Research Ethics Committee of Santiago-Lugo, Spain (registration
code: 2018/510). All patients (and their legal guardians, where appropriate) signed a consent form.
Between February 2019 and June 2019, all individuals with DS who regularly attended educational
or occupational therapy centers in Galicia, Spain, were consecutively selected (Figure S1). The exclusion
criteria were (1) age younger than 18 years; (2) coexistence of systemic diseases that could affect
periodontal health; (3) presence of harmful habits (e.g., smoking); and (4) having taken systemic
antibiotics and/or antimicrobial mouth rinses within the previous 3 months.
2.2. Periodontal Examination
After the recruitment, the patients or their guardians provided information on the patients’ age,
sex, presence of comorbidities and use of current medications. The patients then underwent an intraoral
and periodontal clinical examination, during which the following periodontal variables were recorded
for the 4 sites at the 6 reference teeth [11] or, when absent, at the adjacent tooth: plaque index [12],
probing depth (PD), bleeding on probing (BOP) [13], gingival recession and clinical attachment level
(CAL). These variables were recorded by a trained and calibrated clinical investigator (NL). Calibration
was performed over several sessions of repeated measurements, until the clinical investigator obtained
intra-class correlation coefficients > 0.75.
The case definition of a patient with a healthy periodontal condition was based on a PD < 4 mm
and BOP detected at no more than 2 sites (less than 10% of the total) [14]. A case of periodontitis
was defined when an interdental CAL was detected at 2 or more non-adjacent teeth or when a buccal
or oral CAL ≥ 3 mm with pocketing > 3 mm was detected at 2 or more teeth [15]. Applying these
clinical criteria, we selected a convenience sample consisting of 50 individuals: 25 patients with DS
with periodontitis (PDS) and 25 patients with DS with a healthy periodontal condition (HDS).
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2.3. Microbiological Examination
2.3.1. Subgingival Biofilm Sample Collection
Samples were taken from 4 sites, one in each quadrant, selecting those with the deepest PD and
BOP [16]. The sample collection procedure consisted of isolating the selected area with cotton rolls,
removing the supragingival plaque or calculus. Once each site had been dried with cotton pellets,
two medium-sized sterile paper tips (Maillefer, Ballaigues, Switzerland) were inserted in each site for
10 s, as subgingivally as possible [16]. All paper tips were then pooled in a vial containing 1.5 mm
of reduced transport fluid [17] and sent to the Microbiology Laboratory of the Faculty of Dentistry,
Complutense University, Madrid to be processed within 24 h.
2.3.2. Extraction of Total Genomic DNA
Total DNA was extracted from subgingival samples using a commercial kit (MoIYsis Complete 5.
Molzym Gmbh & Co. KG. Bremen, Germany) following the manufacturer’s instructions (the protocol
for bacterial DNA extraction was followed from step 6, skipping the preliminary steps). The extracted
DNA was eluted in 100 µL of sterile water (Roche Diagnostic GmbH; Mannheim, Germany) and frozen
at −20 ◦C for further analysis. Two negative control blanks, which included no sample, were subjected
to all steps of the DNA extraction and purification procedure described above.
2.3.3. 16S rRNA Gene Sequencing with Illumina® Sequencing
Bacterial DNA from the 50 participants was analyzed by sequencing the 16S rRNA gene V3–V4
hypervariable region using the MiSeq System (Illumina, San Diego, CA, USA). The selection of the
V3–V4 region was based on the fact that it provides a more accurate characterization of the microbiome
samples than V1–V2 [18] and V1–V3 [19]. The 16S rDNA gene amplicons were obtained following
the 16S rDNA gene Metagenomic Sequencing Library Preparation Illumina protocol (Cod. 15044223
Rev. A: Illumina). Illumina adapter overhang nucleotide sequences were added to the gene-specific
sequences. The primers were selected from Klindworth et al. [20] [Forward Primer = 5′ TCG TCG GCA
GCG TCA GAT GTG TAT AAG AGA CAG CCT ACG GGN GGC WGC AG; Reverse Primer = 5′ GTC
TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA GGA CTA CHV GGG TAT CTA ATCC]. Microbial
genomic DNA (5 ng/µL in 10 mMTris pH 8.5) was employed to start the protocol. After 16S rDNA
gene amplification, the multiplexing step was performed using Nextera XT DNA Library Preparation
Kit (FC-131-1096; Illumina). We ran 1 µL of the PCR product in a Bioanalyzer DNA 1000 chip to verify
the size. The libraries were then sequenced using a 2 × 300 pb paired-end run (MiSeq Reagent kit v3
(MS-102-3001); Illumina) on a MiSeq Sequencer according to the manufacturer’s instructions (Illumina).
Quality assessment was performed using the prinseq-lite program [21]. Data were obtained using an
ad hoc pipeline written in the RStatistics environment [22], making use of several open source libraries.
Data were grouped and stratified according to the metadata file provided by the user.
The analysis was performed at the Foundation for the Promotion of Health and Biomedical
Research of the Valencia Region, Valencia, Spain.
2.3.4. Taxonomic Assignment
We analyzed the sequence data obtained from MiSeq using the QIIME2 pipeline [23]. In brief,
denoising, paired-ends joining and chimera depletion was performed starting from paired-ends
data using the DADA2 pipeline [24]. Taxonomic affiliations were assigned using the naïve Bayesian
classifier integrated in the QIIME2 plugins, using a 97% similarity threshold. The database used for
this taxonomic assignation was SILVA_release_132 [25].
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2.4. Statistical and Bioinformatics Analysis
A sample size calculation was not possible because no previous information was available on
the microbiomes of the patients with DS. We selected a convenience sample of 25 patients with PDS,
similar to the 30 patients with periodontitis and DS included by Martinez-Martinez et al. [7].
A subject-level analysis was performed for each demographic and clinical variable in the study.
The data are expressed as mean and standard deviation (SD), prevalence and proportions (%).
After assessing the normality of the variables’ distribution (applying the Kolmogorov–Smirnov test),
we compared the results obtained between the PDS and HDS groups using Student’s t test for the
quantitative variables and the chi-squared test or Fisher’s exact test for the categorical variables.
The statistical significance level was set at p < 0.05. We employed the IBM®SPSS Statistics 21.0 statistics
package (IBM Corporation, Armonk, NY, USA) for the data analysis.
In terms of the diversity and significance analysis, we subjected the sample data obtained in
the biological observation matrix format to statistical analysis using the R statistics environment [22].
We analyzed the samples’ sequencing depth using the Shannon index. We also estimated the
main bacteria and taxonomic composition of the microbiota in each sample. The differences in
bacteria abundance between the sample groups were evaluated using Wilcoxon rank-sum and
Kruskal–Wallis tests among various metadata factors. Applying the phyloseq R package, we employed
4 non-phylogeny-based metrics, namely the Observed species, Chao1metric, abundance-based coverage
estimators (ACE) and Shannon index to evaluate alpha diversity, which represented the amount of
diversity contained within communities. We applied a principal coordinate analysis (PCoA) with
weighted UniFrac distances to evaluate beta diversity, which represented the amount of diversity
shared among communities.
We followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
checklist when reporting the results of the present study (Scheme S1).
3. Results
3.1. Patients Sample
The original sample included 168 patients with DS with an age range of 18–45 years. In the
selected sample, the mean age was not statistically significant between the study groups (p = 0.063).
The sex distribution was similar, and there were no differences in the prevalence of cardiovascular
disease and other systemic conditions. However, thyroid disease showed a greater presence in the
PDS group (p = 0.008) (Table 1).
Table 1. Patient sample characteristics (age, sex and systemic conditions) for the entire sample and for
those with Down syndrome and periodontitis or a healthy periodontium.
Full Sample HDS PDS p *
Age, years mean (SD) 26.8 (6.56) 25.1 (6.18) 28.6 (6.61) 0.063
Sex
Male, n (%) 29 (58) 14 (56) 15 (60) 0.774
Female, n (%) 21 (42) 11 (44) 10 (40) 0.774
Systemic
disease
all conditions, n (%) 21 (42) 11 (44) 10 (40) 0.774
heart disease, n (%) 6 (12) 1 (4) 5 (20) 0.189
thyroid disease, n (%) 12 (24) 10 (40) 2 (8) 0.008
thyroid medication, n (%) 12 (24) 10 (40) 2 (8) 0.008
other conditions, n (%) 6 (12) 3 (12) 3 (12) 1.000
* Student t-test for age; chi-squared test/Fisher’s exact test for categorical variables. Abbreviations: HSD,
Down syndrome with healthy periodontium; PSD, Down syndrome with periodontitis; SD, standard deviation.
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3.2. Clinical Outcome Variables
The periodontal clinical outcomes were significantly different (p < 0.001) between the PDS and
HDS groups for PD, CAL, BOP and the plaque index (Table 2).
Table 2. Periodontal clinical outcome variables, for the whole sample and for the patients with Down
syndrome and periodontitis or a healthy periodontium.
Whole Sample HDS PDS
p *
Mean SD Mean SD Mean SD
PD 2.39 0.47 2.07 0.11 2.72 0.47 <0.0001
CAL 2.45 0.59 2.08 0.13 2.81 0.65 <0.0001
REC 0.08 0.25 0.02 0.06 0.14 0.35 0.0985
BOP 19.9 17.8 7.7 7.7 32.2 16.7 <0.0001
PlI 56.5 31.5 41.8 30.3 71.2 25.8 0.0006
Abbreviations: BOP, bleeding on probing; HSD, Down syndrome with healthy periodontium; CAL, clinical
attachment level; PlI, plaque index PD, probing depth; PSD, Down syndrome with periodontitis; REC, gingival
recession; SD, standard deviation. * Student t test.
3.3. Overall Microbial Sequencing Results
Following the DNA extraction and bar-coded PCR amplification, the samples were sequenced.
After quality filtering, denoising, paired-ends joining and chimera filtering, 50 samples (25 PDS,
25 HDS) were included in the analysis. A total of 5,623,126 reads (median/sample, 114,757; range,
85,827–142,134) were assigned into operational taxonomic units (OTUs). The sequencing depth was
similar between the two groups: 2,226,567 reads for HDS and 2,331,571 reads for PDS. The OTUs were
classified into 13 phyla: Firmicutes (37.17%), Bacteroidetes (19.04%), Proteobacteria (18.20%), Fusobacteria
(15.04%), Actinobacteria (3.70%), Spirochaetes (2.79%), Epsilonbacteraeota (2.10%), Patescibacteria (1.36%),
Synergistetes (0.51%), Chloroflexi (0.04%), Tenericutes (0.03%), Cyanobacteria (0.02%) and Elusimicrobia
(0.01%). These OTUS were further classified into 20 classes, 41 orders, 75 families, 158 genera and
403 species. The diversity is summarized in Figure S2 and was generated using the Krona hierarchical
browser [26].
3.4. Taxonomic Composition of Periodontitis and Healthy Periodontal Patients
Table 3 summarizes the dominant bacteria in the subgingival microbiome of the patients with
DS. The rarefaction analysis showed that the overall diversity was covered by the obtained sequences,
indicating that the microbial composition for each periodontal status was well represented by the
sequencing depth (Figure S3A), showing rarefaction curves at the phylum, genus and species levels.
In terms of community diversity, the PDS and HDS groups presented distinct microbial profiles at
all taxonomic levels, although there were no statistically significant differences in overall diversity
(Figure S3B) at the phylum, genus and species levels. In terms of the relative abundance in the groups,
there were some significant differences (p ≤ 0.05) at various taxonomic levels, specifically in 3 phyla,
5 classes, 4 orders, 2 families, 21 genera and 39 species (Table S1).
In the HDS group, the five most abundant phyla were Firmicutes (38.00%), Proteobacteria (28.23%),
Bacteroidetes (14.56%), Fusobacteria (9.42%) and Actinobacteria (4.11%), which represented more than 94%
of the total sequences (Table 3). In the PDS group, four of the aforementioned phyla also constituted
the majority of the microbiome: Firmicutes (44.04%), Bacteroidetes (20.23%), Proteobacteria (12.04%)
and Fusobacteria (11.09%), although the abundance of Spirochaetes (4.11%) was higher. The five phyla
represented approximately 90% of all sequences (Table 3). Three of the 13 identified phyla showed a
significantly different abundance between the sample groups: Chloroflexi (p = 0.0114) and Synergistetes
(p = 0.0370), which were more abundant in the PDS group, and Proteobacteria (p = 0.0407), which was
more abundant in the HDS group (Table S1).
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At the genus level, the five most abundant genera in the HDS group were Streptococcus (19.55%),
Fusobacterium (6.72%), Neisseria (6.15%), Pseudomonas (5.73%) and Veillonella (4.56%) (Table 3). In contrast,
Streptococcus (23.55%), Fusobacterium (7.48%), Neisseria (5.93%), Porphyromonas (4.59%) and Treponema
(4.10%) were the most abundant genera in the PDS group (Table 3). The PDS group harbored
higher levels of recently described new putative pathogens, such as species of the genera Filifactor,
Fretibacterium and Desulfobulbus [27]. In total, 21 genera were identified with a significantly different
abundance between the groups, including Paludibacteraceae F0058 (p < 0.001), Tannerella (p = 0.029) and
Fretibacterium (p = 0.0371) with a significant abundance in the PDS group compared with the HDS
group, as well as Pseudomonas (p = 0.0028), which were more abundant in the HDS group (Table S1).
Table 3. Dominant operational taxonomic units and their proportions (in percentage) in the patients
with Down syndrome and periodontitis or a healthy periodontal condition, at all taxonomic levels.
Phylum Class
HDS PDS HDS PDS
Firmicutes 38.00 Firmicutes 44.04 Gammaproteobacteria 28.16 Bacilli 29.27
Proteobacteria 28.23 Bacteroidetes 20.23 Bacilli 26.63 Bacteroidia 20.23
Bacteroidetes 14.56 Proteobacteria 12.04 Bacteroidia 14.56 Gammaproteobacteria 11.83
Fusobacteria 9.42 Fusobacteria 11.09 Fusobacteriia 9.42 Fusobacteriia 11.09
Actinobacteria 4.11 Spirochaetes 4.10 Negativicutes 7.67 Negativicutes 8.66
Epsilonbacteraeota 2.58 Actinobacteria 3.71 Actinobacteria 4.04 Spirochaetia 4.10
Spirochaetes 1.78 Epsilonbacteraeota 2.49 Clostridia 3.65 Clostridia 6.02
Patescibacteria 1.17 Patescibacteria 1.74 Campylobacteria 2.58 Actinobacteria 3.42
Synergistetes 0.11 Synergistetes 0.39 Spirochaetia 1.78 Campylobacteria 2.49
Cyanobacteria 0.03 Chloroflexi 0.08 Gracilibacteria 0.16 Coriobacteriia 0.30
Order Family
HDS PDS HDS PDS
Lactobacillales 23.63 Lactobacillales 26.69 Streptococcaceae 19.56 Streptococcaceae 23.55
Betaproteobacteriales 10.60 Bacteroidales 16.02 Neisseriaceae 7.67 Veillonellaceae 8.66
Fusobacteriales 9.42 Fusobacteriales 11.09 Veillonellaceae 7.06 Fusobacteriaceae 7.48
Bacteroidales 9.40 Selenomonadales 8.66 Fusobacteriaceae 6.72 Neisseriaceae 7.23
Selenomonadales 7.67 Betaproteobacteriales 7.71 Prevotellaceae 5.75 Prevotellaceae 6.13
Pseudomonadales 5.73 Clostridiales 6.02 Pseudomonadaceae 5.73 Porphyromonadaceae 4.59
Pasteurellales 5.35 Spirochaetales 4.10 Pasteurellaceae 5.35 Spirochaetaceae 4.10
Flavobacteriales 4.87 Pasteurellales 3.5 Carnobacteriaceae 3.77 Leptotrichiaceae 3.61
Clostridiales 3.65 Flavobacteriales 3.37 Enterobacteriaceae 3.47 Pasteurellaceae 3.50
Enterobacteriales 3.47 Bacillales 2.57 Flavobacteriaceae 3.32 Flavobacteriaceae 3.16
Genus Species
HDS PDS HDS PDS
Streptococcus 19.56 Streptococcus 23.55 Streptococcus u. spp.a 17.83 Streptococcus u. spp. 21.48
Fusobacterium 6.72 Fusobacterium 7.48 Fusobacterium u. spp. 6.72 Fusobacterium u. spp. 7.35
Neisseria 6.15 Neisseria 5.93 Pseudomonas u. spp. 5.73 Neisseria u. spp. 4.73
Pseudomonas 5.73 Porphyromonas 4.59 Granulicatella u. spp. 3.63 Veillonella u. spp. 4.11
Veillonella 4.56 Treponema 2 4.10 Neisseria u.b. 3.28 Paludibacteraceae F0058 u. spp. 3.05
Granulicatella 3.77 Veillonella 4.10 Haemophilus u. spp. 2.59 Granulicatella u. spp. 2.86
Haemophilus 3.33 Leptotrichia 3.61 Delftia u. spp. 2.52 Porphyromonas u. spp. 2.23
Capnocytophaga 3.18 Capnocytophaga 3.16 Neisseria u. spp. 2.44 Gemella u. spp. 1.89
Gemella 2.99 Gemella 2.57 Stenotrophomonas u. spp. 2.28 Tannerella u. spp. 1.56
Leptotrichia 2.71 Granulicatella 2.91 Gemella u. spp. 1.79 Porphyromonas u. spp. 1.43
Abbreviations: HSD, Down syndrome with healthy periodontium; PSD, Down syndrome with periodontitis.
Table 3 shows the dominant species in both groups. Streptococcus spp. was the most abundant
species in both the HDS and PDS groups (17.83% and 21.5%, respectively), followed by Fusobacterium
spp. (6.72% and 7.35%, respectively). The most abundant species in the HDS group included those of
the Pseudomonas, Granulicatella and Gemella genera. In the PDS group, in contrast, the most abundant
species were those of the Porphyromonas and Tannerella genera. Table S1 shows the 39 bacterial species
with significant differences between the HDS and PDS groups.
As shown in Figure S3B, the average richness measured by the Observed, Chao1 and ACE
indices was higher in the samples from the PDS group than in samples from the HDS group, although
without statistical significance. The ACE and Shannon diversity indices had an identical trend. Thus,
the relative abundance of each bacterium was more balanced in the samples from the HDS group than
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in samples from the PDS group, and there were more bacteria with low relative abundance in the
samples from the PDS group. The Simpson index confirms this fact, demonstrating greater uniformity
at all taxonomic levels in the HDS group, although without significant differences.
To evaluate the similarity of the microbial community structure among the samples and thereby
explore the relationships between the bacterial communities in the PDS and HDS groups, we performed
a PCoA. The results showed a distinction between the microbial compositions of the two groups
at all taxonomic levels, given that the PDS and HDS groups could not be grouped into one cluster
(Figure S4). The HDS group appeared more clustered, unlike the PDS group, which appeared more
dispersed. The clusters showed that dispersion was produced by 20% of the periodontitis samples,
which presented a dissimilar bacterial community among all samples.
4. Discussion
The present study aimed to describe (through the use of NGS) the subgingival microbiome of
patients with DS and periodontitis and compare it with the microbiome of patients with DS without
periodontitis. The results have shown significant differences between the oral microbiome of the HDS
and PDS groups at various taxonomical levels.
The PDS group harbored higher levels of well-recognized periodontal pathogens, such as Tannerella,
Treponema, Porphyromonas and Aggregatibacter (p < 0.05), as well as recently described new putative
pathogens, such as Peptostreptococcus, Filifactor, Fretibacterium and Desulfobulbus [25], all of which
demonstrated greater relative abundance at the genus level in the PDS group. In contrast, a set of
bacterial species, including Veillonella, Neisseria, Gemella and Granulicatella were significantly frequent
in the samples from the HDS group. These results agree with those of studies on the subgingival
microbiota and microbiome in the general population [28–32]. However, there are some discrepancies,
mainly in certain species considered compatible with periodontal health such as those from the
Streptococcus and Selenomonas genera that were more abundant in the samples from the PDS group
than from the HDS group. We found higher levels of alpha diversity in the PDS group when compared
with the HDS group, although these differences were not statistically significant. This diversity might
be associated with the patients’ reduced immune competence or with a richer environment in nutrients
as a result of the onset of periodontitis, which is in line with previous studies that reported higher
bacterial community diversity in different “stages” of periodontitis, when compared with individuals
with a healthy periodontal condition [33–35].
Although various studies have characterized the subgingival microbiome in patients with and
without periodontitis using metagenomic approaches [36,37], the present study is, to the best of
our knowledge, the first to evaluate the subgingival microbiome of patients with DS using NGS
technology. Our findings corroborate those of previous studies that reported higher mean counts
of all “red complex” species and lower counts of Actinomyces in patients with periodontitis using
checkerboard DNA–DNA hybridization [6], as well as a higher prevalence of Tannerella, Treponema,
Porphyromonas and Aggregatibacter genera in patients with periodontitis (using PCR) [7]. It stands to
reason that the analysis performed using NGS in the present study not only corroborates the results
using other techniques but also makes the techniques more comprehensive because the use of NGS
techniques results in high throughputs, enabling the processing of thousands or even millions of
sequences, which can result in the inaccurate identification of microbial taxa, including uncultivable
organisms and those present in small numbers.
The results from this study, however, also present certain limitations. At the microbiological
level, certain taxa cannot be distinguished with species-level taxonomic resolution when the 16S rRNA
sequencing employed the QIIME pipeline for the downstream taxonomic classification, which might
result in some unclassified OTUS such as Porphyromonas_Unidentified at the species level [38–41].
To solve this limitation, other authors have analyzed the reads generated by MiSeq with HOMINGS,
an in silico probe-based platform [42].
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At the clinical level, the periodontal diagnosis was based on the clinical assessment restricted to
the Ramfjord teeth, which were chosen to facilitate the examination of the special patient population
included in the study and due to the well-known evidence that partial-mouth recording systems might
present adequate accuracy. Differences at baseline (although not statistically significant) should also
be discussed as a limitation because the PDS group was slightly older, while the HDS group more
frequently had thyroid diseases and were taking drugs for the condition. Finally, a larger sample
size would have been desirable; however, there were no previous studies for a proper sample size
calculation. We therefore selected a convenience sample [7].
5. Conclusions
Considering the abovementioned limitations of this cross-sectional study, the use of 16S
rRNA-based NGS analysis of subgingival samples from patients with Down syndrome suggests
a quite distinct subgingival microbiome in periodontitis versus that of periodontally healthy controls.
The PDS group showed a more complex bacterial composition with a higher number of pathogens but
not at the expense of a depletion of host-compatible species. Well-recognized periodontal pathogens
(including Porphyromonas, Treponema, Tannerella and Aggregatibacter) as well as newly proposed
pathogenic taxa (Peptostreptococcus, Filifactor, Fretibacterium and Desulfobulbus) were associated with
periodontitis in the patients with Down syndrome.
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